title: Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?
authors.affiliation: Department of Medical Oncology. Electronic address: lucia.delmastro@istge.it.
authors.forename: L
authors.initials: L
authors.lastname: Del Mastro
authors.affiliation: Department of Medical Oncology.
authors.forename: C
authors.initials: C
authors.lastname: Bighin
authors.affiliation: Department of Medical Oncology.
authors.forename: G
authors.initials: G
authors.lastname: Bini
authors.affiliation: Department of Medical Oncology.
authors.forename: S
authors.initials: S
authors.lastname: Giraudi
authors.affiliation: Department of Medical Oncology.
authors.forename: P
authors.initials: P
authors.lastname: Taveggia
authors.affiliation: Department of Medical Oncology.
authors.forename: A
authors.initials: A
authors.lastname: Levaggi
authors.affiliation: Department of Surgical Oncology.
authors.forename: G
authors.initials: G
authors.lastname: Canavese
authors.affiliation: Department of Radiology, National Cancer Research Institute, Genoa, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Rescinito
authors.affiliation: Department of Medical Oncology.
authors.forename: P
authors.initials: P
authors.lastname: Pronzato
mesh_terms: D018943:Anthracyclines / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery*; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery*; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D000068878:Trastuzumab
chemical_list: D018943:Anthracyclines; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human